Advertising
Health & Medicine
Sorry, those blue-blocking lenses probably won’t help your digital eye strain
Eye strain from extended screen time is a growing problem, but evidence suggests that blue light is not the cause, and blue-blockers are not the solution
Politics & Society
The Facebook trick online gambling is using to target Australians
New research has found some overseas online casinos are illegally targeting Australians using Facebook ads – and it’s a big problem
Health & Medicine
How fear-appeal advertising works
The research shows that using fear in advertising can be effective in changing behaviour, but it needs to be done well
Health & Medicine
Our love of sport is now a gateway to gambling
The multi-million dollar fine on a betting company should spur us to finally disentangle gambling from our beloved sports
Politics & Society
Australia vs Facebook: Regulating the market of attention
Facebook’s move to block Australian users and publishers from viewing or sharing news may look like it’s about content – but it all comes back to advertising revenue
Business & Economics
Podcast
What makes super-viral content so shareable?
Dr Brent Coker researches what makes social media content shareable. He reveals what psychological triggers evoke sharing motives, and how they are activated
Health & Medicine
Will the “hard-hitting” COVID-19 ads have the desired impact?
The COVID-19 advertisements are helping to individualise the impact of the pandemic, but are they are hard-hitting enough to change behaviour?
Business & Economics
Thinking about using donated eggs to start a family?
In Australia, the donor egg industry is heavily regulated, but in countries like the US, it can feel more like online shopping. Here’s what you need to know
Business & Economics
The battle of the slogans
As we head toward the federal election, which party has the most effective slogan? We asked a political marketing expert to assess how Australia’s parties are communicating
Business & Economics
They’re using my face
What cosmetic bloggers and the Cambridge Analytica saga tell us about protection from misleading conduct